Yuanting Gu

1.2k total citations
22 papers, 696 citations indexed

About

Yuanting Gu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuanting Gu has authored 22 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yuanting Gu's work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). Yuanting Gu is often cited by papers focused on MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). Yuanting Gu collaborates with scholars based in China, Australia and India. Yuanting Gu's co-authors include Mingli Han, Xin Ge, Dongwei Dou, Nan Wang, Youyi Xiong, Xiaodong Xu, Lin Li, Xiaoyang Ren, Xinxing Wang and Xinguang Qiu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuanting Gu

21 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanting Gu China 13 539 402 119 60 31 22 696
Jingyu Zhang China 14 401 0.7× 205 0.5× 116 1.0× 65 1.1× 31 1.0× 41 611
Pei Li China 15 427 0.8× 337 0.8× 71 0.6× 44 0.7× 32 1.0× 27 581
Yunpeng Sun China 14 615 1.1× 371 0.9× 71 0.6× 61 1.0× 21 0.7× 55 818
Chunlian Wu China 11 411 0.8× 257 0.6× 93 0.8× 39 0.7× 17 0.5× 15 639
Lin Zou China 15 531 1.0× 310 0.8× 105 0.9× 40 0.7× 59 1.9× 27 760
Jung‐Yu Kan Taiwan 15 341 0.6× 226 0.6× 138 1.2× 74 1.2× 32 1.0× 29 561
Xiaoling Luo China 15 347 0.6× 257 0.6× 94 0.8× 44 0.7× 63 2.0× 31 528
Yi Pei China 12 368 0.7× 290 0.7× 71 0.6× 42 0.7× 26 0.8× 26 492

Countries citing papers authored by Yuanting Gu

Since Specialization
Citations

This map shows the geographic impact of Yuanting Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanting Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanting Gu more than expected).

Fields of papers citing papers by Yuanting Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanting Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanting Gu. The network helps show where Yuanting Gu may publish in the future.

Co-authorship network of co-authors of Yuanting Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanting Gu. A scholar is included among the top collaborators of Yuanting Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanting Gu. Yuanting Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shao, Zhi‐Ming, Jihui Hao, Shui Wang, et al.. (2025). Dalpiciclib (Dalp) plus endocrine therapy (ET) as adjuvant treatment for HR+/HER2– early breast cancer (BC): The randomized, phase 3, DAWNA-A trial.. Journal of Clinical Oncology. 43(16_suppl). 515–515. 1 indexed citations
3.
Xiong, Youyi, Lin Li, Nan Wang, et al.. (2023). Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR‐136‐5p. Thoracic Cancer. 14(18). 1707–1718. 4 indexed citations
4.
Wang, Fang, Jingruo Li, Lin Li, et al.. (2022). Circular RNA circ_IRAK3 contributes to tumor growth through upregulating KIF2A via adsorbing miR-603 in breast cancer. Cancer Cell International. 22(1). 81–81. 9 indexed citations
5.
Wang, Nan, et al.. (2022). Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer. Journal of Inflammation Research. Volume 15. 3477–3499. 4 indexed citations
6.
Wang, Nan, Yuanting Gu, Lin Li, et al.. (2022). Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes. Scientific Reports. 12(1). 13766–13766. 10 indexed citations
7.
8.
Wang, Fang, Xiaochun Wang, Jingruo Li, et al.. (2021). CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling. Journal of Biomedical Science. 28(1). 4–4. 34 indexed citations
9.
10.
Wang, Nan, Yuanting Gu, Xinwei Liu, et al.. (2021). Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics. Frontiers in Genetics. 12. 721873–721873. 5 indexed citations
11.
Wang, Fang, Xiaochun Wang, Jingruo Li, et al.. (2021). Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling. Journal of Biomedical Science. 28(1). 31–31. 4 indexed citations
12.
Chen, Zhuo, et al.. (2020). CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression. Cancer Cell International. 20(1). 400–400. 45 indexed citations
13.
Dou, Dongwei, Xiaoyang Ren, Mingli Han, et al.. (2020). CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell International. 20(1). 454–454. 79 indexed citations
14.
Chen, Kuo, Pengwei Lu, Narasimha M. Beeraka, et al.. (2020). Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers. Seminars in Cancer Biology. 83. 556–569. 160 indexed citations
15.
Wang, Xiaochun, Fang Wang, Lin Li, et al.. (2020). <p>SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381</p>. OncoTargets and Therapy. Volume 13. 657–666. 30 indexed citations
16.
Dou, Dongwei, Xin Ge, Xinxing Wang, et al.. (2019). <p>EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression</p>. OncoTargets and Therapy. Volume 12. 9627–9637. 29 indexed citations
17.
Han, Mingli, Yimeng Wang, Li Lin, et al.. (2018). microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway. Journal of Cellular Biochemistry. 119(10). 8138–8145. 35 indexed citations
18.
Wang, Nan, Yuanting Gu, Lin Li, et al.. (2018). Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. Archives of Biochemistry and Biophysics. 653. 63–70. 33 indexed citations
19.
Zhu, Mingzhi, Xiaochun Wang, Yuanting Gu, et al.. (2018). MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway. Archives of Biochemistry and Biophysics. 661. 22–30. 64 indexed citations
20.
Ge, Xin, Yuanting Gu, Lin Li, et al.. (2015). Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: Modulation of PFKFB3 activation. Biochemical and Biophysical Research Communications. 464(3). 862–868. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingyu Zhang Breakdown of academic impact, for papers by Pei Li Breakdown of academic impact, for papers by Yunpeng Sun Breakdown of academic impact, for papers by Chunlian Wu Breakdown of academic impact, for papers by Lin Zou Breakdown of academic impact, for papers by Jung‐Yu Kan Breakdown of academic impact, for papers by Xiaoling Luo Breakdown of academic impact, for papers by Yi Pei
Rankless by CCL
2026